{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T05:02:35Z","timestamp":1773810155855,"version":"3.50.1"},"reference-count":62,"publisher":"Elsevier BV","issue":"41","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.vaccine.2023.08.036","type":"journal-article","created":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T07:46:36Z","timestamp":1692776796000},"page":"6008-6016","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Development and characterization of a plant-derived norovirus-like particle vaccine"],"prefix":"10.1016","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8088-2506","authenticated-orcid":false,"given":"Janna R.","family":"Shapiro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guadalupe","family":"Andreani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlotte","family":"Dub\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00e9lanie","family":"Berub\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diane","family":"Bussi\u00e8re","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manon M.-J.","family":"Couture","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mich\u00e8le","family":"Dargis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0205-5692","authenticated-orcid":false,"given":"Hilary E.","family":"Hendin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathalie","family":"Landry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9994-2417","authenticated-orcid":false,"given":"Pierre-Olivier","family":"Lavoie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"St\u00e9phane","family":"Pillet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3251-958X","authenticated-orcid":false,"given":"Brian J.","family":"Ward","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc-Andr\u00e9","family":"D'Aoust","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0283-372X","authenticated-orcid":false,"given":"Sonia","family":"Tr\u00e9panier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2023.08.036_b0005","doi-asserted-by":"crossref","first-page":"79","DOI":"10.12688\/f1000research.10081.1","article-title":"Recent advances in understanding noroviruses","volume":"6","author":"Bartnicki","year":"2017","journal-title":"F1000Res"},{"key":"10.1016\/j.vaccine.2023.08.036_b0010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001999","article-title":"The vast and varied global burden of norovirus: prospects for prevention and control","volume":"13","author":"Lopman","year":"2016","journal-title":"PLoS Med"},{"key":"10.1016\/j.vaccine.2023.08.036_b0015","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1056\/NEJMra0804575","article-title":"Norovirus gastroenteritis","volume":"361","author":"Glass","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2023.08.036_b0020","doi-asserted-by":"crossref","first-page":"2742","DOI":"10.1002\/eji.201545512","article-title":"Norovirus immunology: of mice and mechanisms","volume":"45","author":"Newman","year":"2015","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2023.08.036_b0025","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01032-13","article-title":"The effect of malnutrition on norovirus infection","volume":"5","author":"Hickman","year":"2014","journal-title":"MBio"},{"key":"10.1016\/j.vaccine.2023.08.036_b0030","doi-asserted-by":"crossref","first-page":"3528","DOI":"10.1017\/S0950268815000734","article-title":"Estimated hospitalizations attributed to norovirus and rotavirus infection in Canada, 2006\u20132010","volume":"143","author":"Morton","year":"2015","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2023.08.036_b0035","doi-asserted-by":"crossref","first-page":"e0151219","DOI":"10.1371\/journal.pone.0151219","article-title":"Global economic burden of norovirus gastroenteritis","volume":"11","author":"Bartsch","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2023.08.036_b0040","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.3389\/fimmu.2020.01383","article-title":"Norovirus vaccine: priorities for future research and development","volume":"11","author":"Esposito","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2023.08.036_b0045","first-page":"1653","article-title":"Norovirus vaccines: correlates of protection, challenges and limitations","volume":"12","author":"Melhem","year":"2016","journal-title":"Hum Vacc Immunother"},{"key":"10.1016\/j.vaccine.2023.08.036_b0050","doi-asserted-by":"crossref","DOI":"10.1002\/rmv.2354","article-title":"Global and regional circulation trends of norovirus genotypes and recombinants, 1995\u20132019: a comprehensive review of sequences from public databases","volume":"32","author":"Kendra","year":"2022","journal-title":"Rev Med Virol"},{"key":"10.1016\/j.vaccine.2023.08.036_b0055","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.3201\/eid2006.131627","article-title":"Sequential gastroenteritis episodes caused by 2 norovirus genotypes","volume":"20","author":"Parra","year":"2014","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2023.08.036_b0060","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1093\/infdis\/161.1.18","article-title":"Multiple-challenge study of host susceptibility to Norwalk gastroenteritis in US adults","volume":"161","author":"Johnson","year":"1990","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2023.08.036_b0065","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1056\/NEJM197707142970204","article-title":"Clinical immunity in acute gastroenteritis caused by Norwalk agent","volume":"297","author":"Parrino","year":"1977","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2023.08.036_b0070","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.3201\/eid1908.130472","article-title":"Duration of immunity to norovirus gastroenteritis","volume":"19","author":"Simmons","year":"2013","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2023.08.036_b0075","doi-asserted-by":"crossref","first-page":"547","DOI":"10.3390\/v11060547","article-title":"In vitro replication of human norovirus","volume":"11","author":"Bhar","year":"2019","journal-title":"Viruses"},{"key":"10.1016\/j.vaccine.2023.08.036_b0080","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1586\/erv.10.115","article-title":"Virus-like particles in vaccine development","volume":"9","author":"Rold\u00e3o","year":"2010","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2023.08.036_b0085","doi-asserted-by":"crossref","unstructured":"Mohsen MO, Zha L, Cabral-Miranda G, Bachmann MF. Major findings and recent advances in virus\u2013like particle (VLP)-based vaccines. Seminars in immunology: Elsevier; 2017. p. 123-32.","DOI":"10.1016\/j.smim.2017.08.014"},{"key":"10.1016\/j.vaccine.2023.08.036_b0090","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.nbt.2017.07.010","article-title":"Production of virus-like particles for vaccines","volume":"39","author":"Fuenmayor","year":"2017","journal-title":"N Biotechnol"},{"key":"10.1016\/j.vaccine.2023.08.036_b0095","doi-asserted-by":"crossref","unstructured":"Chen Q. Virus-like particle vaccines for norovirus gastroenteritis. Molecular Vaccines: From Prophylaxis to Therapy-Volume 1. 2013:153-81.","DOI":"10.1007\/978-3-7091-1419-3_8"},{"key":"10.1016\/j.vaccine.2023.08.036_b0100","doi-asserted-by":"crossref","first-page":"6527","DOI":"10.1128\/jvi.66.11.6527-6532.1992","article-title":"Expression, self-assembly, and antigenicity of the Norwalk virus capsid protein","volume":"66","author":"Jiang","year":"1992","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2023.08.036_b0105","first-page":"10","article-title":"norovirus vaccines: current clinical development and challenges","author":"Tan","year":"2021","journal-title":"Pathogens"},{"key":"10.1016\/j.vaccine.2023.08.036_b0110","doi-asserted-by":"crossref","first-page":"3588","DOI":"10.1016\/j.vaccine.2022.04.089","article-title":"Immunogenicity of a bivalent virus-like particle norovirus vaccine in children from 1 to 8 years of age: a phase 2 randomized, double-blind study","volume":"40","author":"Vesikari","year":"2022","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.08.036_b0115","doi-asserted-by":"crossref","unstructured":"Kawagishi T, S\u00e1nchez-Tacuba L, Feng N, Costantini VP, Tan M, Jiang X, et al. Mucosal and systemic neutralizing antibodies to norovirus induced in infant mice orally inoculated with recombinant rotaviruses. Proc Nat Acad Sci USA 2023;120:e2214421120.","DOI":"10.1073\/pnas.2214421120"},{"key":"10.1016\/j.vaccine.2023.08.036_b0120","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1021500","article-title":"A randomized, double-blind, placebo-controlled, dose-escalating phase I trial to evaluate safety and immunogenicity of a plant-produced, bivalent, recombinant norovirus-like particle vaccine","volume":"13","author":"Leroux-Roels","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2023.08.036_b0125","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1056\/NEJMoa1101245","article-title":"Norovirus vaccine against experimental human Norwalk Virus illness","volume":"365","author":"Atmar","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2023.08.036_b0130","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.copbio.2015.12.007","article-title":"Molecular pharming\u2014VLPs made in plants","volume":"37","author":"Marsian","year":"2016","journal-title":"Curr Opin Biotechnol"},{"key":"10.1016\/j.vaccine.2023.08.036_b0135","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/j.1467-7652.2009.00496.x","article-title":"The production of hemagglutinin-based virus-like particles in plants: a rapid, efficient and safe response to pandemic influenza","volume":"8","author":"D\u2019Aoust","year":"2010","journal-title":"Plant Biotechnol J"},{"key":"10.1016\/j.vaccine.2023.08.036_b0140","doi-asserted-by":"crossref","first-page":"6282","DOI":"10.1016\/j.vaccine.2015.09.065","article-title":"Plant-derived H7 VLP vaccine elicits protective immune response against H7N9 influenza virus in mice and ferrets","volume":"33","author":"Pillet","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.08.036_b0145","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1016\/S0140-6736(20)32014-6","article-title":"Efficacy, immunogenicity, and safety of a plant-derived, quadrivalent, virus-like particle influenza vaccine in adults (18\u201364 years) and older adults (\u226565 years): two multicentre, randomised phase 3 trials","volume":"396","author":"Ward","year":"2020","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.vaccine.2023.08.036_b0150","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0151842","article-title":"Immunological characterization of plant-based HIV-1 Gag\/Dgp41 virus-like particles","volume":"11","author":"Kessans","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2023.08.036_b0155","article-title":"Hepatitis B core-based virus-like particles: A platform for vaccine development in plants","volume":"29","author":"Moradi Vahdat","year":"2021","journal-title":"Biotechnol Rep (Amst)"},{"key":"10.1016\/j.vaccine.2023.08.036_b0160","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/s41423-021-00809-2","article-title":"Safety, immunogenicity, and protection provided by unadjuvanted and adjuvanted formulations of a recombinant plant-derived virus-like particle vaccine candidate for COVID-19 in nonhuman primates","volume":"19","author":"Pillet","year":"2022","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.vaccine.2023.08.036_b0165","doi-asserted-by":"crossref","first-page":"4017","DOI":"10.1016\/j.vaccine.2022.05.046","article-title":"Broad neutralization against SARS-CoV-2 variants induced by ancestral and B. 1.351 AS03-adjuvanted recombinant plant-derived virus-like particle vaccines","volume":"40","author":"Dub\u00e9","year":"2022","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.08.036_b0170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0216533","article-title":"Immunogenicity and safety of a quadrivalent plant-derived virus like particle influenza vaccine candidate\u2014two randomized Phase II clinical trials in 18 to 49 and\u2265 50 years old adults","volume":"14","author":"Pillet","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2023.08.036_b0175","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1056\/NEJMoa2201300","article-title":"Efficacy and safety of a recombinant plant-based adjuvanted covid-19 vaccine","volume":"386","author":"Hager","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2023.08.036_b0180","series-title":"Molecular cloning: a laboratory manual","author":"Russell","year":"2001"},{"key":"10.1016\/j.vaccine.2023.08.036_b0185","doi-asserted-by":"crossref","first-page":"200","DOI":"10.3389\/fpls.2016.00200","article-title":"5\u2032 and 3\u2032 untranslated regions strongly enhance performance of geminiviral replicons in Nicotiana benthamiana leaves","volume":"7","author":"Diamos","year":"2016","journal-title":"Front Plant Sci"},{"key":"10.1016\/j.vaccine.2023.08.036_b0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1746-4811-4-4","article-title":"Protocol: streamline cloning of genes into binary vectors in Agrobacterium via the Gateway\u00ae TOPO vector system","volume":"4","author":"Xu","year":"2008","journal-title":"Plant Methods"},{"key":"10.1016\/j.vaccine.2023.08.036_b0195","doi-asserted-by":"crossref","DOI":"10.1039\/D3AY00411B","article-title":"An isotope dilution mass spectrometry assay to track Norovirus-like particles in vaccine process intermediates by quantifying capsid protein VP1","author":"Jhingree","year":"2023","journal-title":"Anal Methods"},{"key":"10.1016\/j.vaccine.2023.08.036_b0200","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/s11427-010-4104-3","article-title":"Immunogenicity and virus-like particle formation of rotavirus capsid proteins produced in transgenic plants","volume":"54","author":"Yang","year":"2011","journal-title":"Sci China Life Sci"},{"key":"10.1016\/j.vaccine.2023.08.036_b0205","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1128\/IAI.71.5.2326-2330.2003","article-title":"Brucella abortus RB51 induces protection in mice orally infected with the virulent strain B. abortus 2308","volume":"71","author":"Pasquali","year":"2003","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2023.08.036_b0210","doi-asserted-by":"crossref","first-page":"8448","DOI":"10.1016\/j.vaccine.2007.09.040","article-title":"A human norovirus-like particle vaccine adjuvanted with ISCOM or mLT induces cytokine and antibody responses and protection to the homologous GII. 4 human norovirus in a gnotobiotic pig disease model","volume":"25","author":"Souza","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.08.036_b0215","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/s41541-022-00463-3","article-title":"Elimination of receptor binding by influenza hemagglutinin improves vaccine-induced immunity","volume":"7","author":"Hendin","year":"2022","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.vaccine.2023.08.036_b0220","doi-asserted-by":"crossref","first-page":"5117","DOI":"10.1128\/jvi.68.8.5117-5125.1994","article-title":"Three-dimensional structure of baculovirus-expressed Norwalk virus capsids","volume":"68","author":"Prasad","year":"1994","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2023.08.036_b0225","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1016\/S0140-6736(20)32014-6","article-title":"Efficacy, immunogenicity, and safety of a plant-derived, quadrivalent, virus-like particle influenza vaccine in adults (18\u201364 years) and older adults (\u2265 65 years): two multicentre, randomised phase 3 trials","volume":"396","author":"Ward","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2023.08.036_b0230","doi-asserted-by":"crossref","first-page":"e01716","DOI":"10.1128\/jvi.01716-22","article-title":"Minimal antigenic evolution after a decade of norovirus GII.4 Sydney_2012 circulation in humans","volume":"97","author":"Parra","year":"2023","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2023.08.036_b0235","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1093\/cid\/ciaa019","article-title":"Homotypic and heterotypic protection and risk of re-infection following natural norovirus infection in a highly endemic setting","volume":"72","author":"Chhabra","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2023.08.036_b0240","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005719","article-title":"Frequent use of the IgA isotype in human B Cells encoding potent norovirus-specific monoclonal antibodies that block HBGA binding","volume":"12","author":"Sapparapu","year":"2016","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2023.08.036_b0245","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1086\/656364","article-title":"Serologic correlate of protection against norovirus-induced gastroenteritis","volume":"202","author":"Reeck","year":"2010","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2023.08.036_b0250","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/infdis\/jiv053","article-title":"Mucosal and cellular immune responses to norwalk virus","volume":"212","author":"Ramani","year":"2015","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2023.08.036_b0255","doi-asserted-by":"crossref","first-page":"3282","DOI":"10.4049\/jimmunol.1900481","article-title":"Immune-focusing properties of virus-like particles improve protective IgA responses","volume":"203","author":"Onodera","year":"2019","journal-title":"J Immunol (Baltimore, Md: 1950)"},{"key":"10.1016\/j.vaccine.2023.08.036_b0260","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1089\/vim.2015.0141","article-title":"Mucosal antibodies induced by intranasal but not intramuscular immunization block Norovirus GII. 4 virus-like particle receptor binding","volume":"29","author":"Tamminen","year":"2016","journal-title":"Viral Immunol"},{"key":"10.1016\/j.vaccine.2023.08.036_b0265","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jcmgh.2020.03.006","article-title":"Virus-host interactions between nonsecretors and human norovirus","volume":"10","author":"Lindesmith","year":"2020","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"10.1016\/j.vaccine.2023.08.036_b0270","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/j.jcmgh.2020.12.012","article-title":"Norovirus-specific CD8(+) T cell responses in human blood and tissues","volume":"11","author":"Pattekar","year":"2021","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"10.1016\/j.vaccine.2023.08.036_b0275","first-page":"732","article-title":"Advances in human norovirus vaccine research","volume":"9","author":"Zhang","year":"2021","journal-title":"Nato Adv Sci Inst Se"},{"key":"10.1016\/j.vaccine.2023.08.036_b0280","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1080\/14760584.2020.1777860","article-title":"Recent advances in human norovirus research and implications for candidate vaccines","volume":"19","author":"Cates","year":"2020","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2023.08.036_b0285","doi-asserted-by":"crossref","first-page":"22","DOI":"10.7326\/M19-1182","article-title":"Effectiveness and cost-effectiveness of human papillomavirus vaccination through age 45 years in the United States","volume":"172","author":"Laprise","year":"2020","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.vaccine.2023.08.036_b0290","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.3390\/pathogens10121641","article-title":"Norovirus vaccines: current clinical development and challenges","volume":"10","author":"Tan","year":"2021","journal-title":"Pathogens"},{"key":"10.1016\/j.vaccine.2023.08.036_b0295","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/mi.2009.22","article-title":"Enteric vaccines for the developing world: a challenge for mucosal immunology","volume":"2","author":"Czerkinsky","year":"2009","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.vaccine.2023.08.036_b0300","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.addr.2015.03.007","article-title":"Delivery strategies to enhance oral vaccination against enteric infections","volume":"91","author":"Davitt","year":"2015","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.vaccine.2023.08.036_b0305","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0036446","article-title":"Quantitative RT-PCR profiling of the rabbit immune response: assessment of acute Shigella flexneri infection","volume":"7","author":"Schnupf","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2023.08.036_b0310","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.vaccine.2022.01.009","article-title":"Safety and immunogenicity studies in animal models support clinical development of a bivalent norovirus-like particle vaccine produced in plants","volume":"40","author":"Tus\u00e9","year":"2022","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X23009684?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X23009684?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:29:59Z","timestamp":1759404599000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X23009684"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":62,"journal-issue":{"issue":"41","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S0264410X23009684"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.08.036","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and characterization of a plant-derived norovirus-like particle vaccine","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.08.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}